Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
FDA is seeking public feedback by Nov. 20 on trial design and safety oversight for the studies, which will examine opioid addiction and PTSD. Heart risks are the key hurdle.
US health officials are moving forward with the first government-funded clinical trials of the psychedelic drug ibogaine, aiming to treat opioid addiction and post-traumatic stress disorder.